CAR T-Cell Therapy Is Safe, Effective in Lymphoma – Curetoday.com
Curetoday.com |
CAR T-Cell Therapy Is Safe, Effective in Lymphoma
Curetoday.com Axicabtagene ciloleucel (KTE-C19), a CAR T-cell therapy, can safely be used and lead to durable complete remission (CR) after more than 12 months for patients with refractory diffuse large B-cell lymphoma (DLBCL), according to the results from a phase … |
